Comparison of Conventional and Tele-cardiac Rehabilitation

NCT06614634 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-09-26

No results posted yet for this study

Summary

This study aimed to compare the effects of tele-cardiac rehabilitation (TCR) and hospital-based cardiac rehabilitation (HBCR) on functional capacity (maximum oxygen consumption), fear of activity and quality of life in patients with coronary artery disease. CAD). The rehabilitation program included patient-specific aerobic and peripheral muscle strengthening exercises for four weeks and 3 sessions per week. While the HBCR group performed the exercise program under supervision in the cardiac rehabilitation (CR) unit, the TCR group performed the exercise program at home/outdoors using a Polar H9 heart rate monitor and elastic band.

Conditions

Interventions

OTHER

Remotely supervised exercise at home or outdoors

Aerobic and strengthening exercise program at home/outdoors at least three days a week for four weeks using a Polar H9 heart rate monitor and elastic band.

OTHER

Hospital-based exercise program

The aerobic and strengthening exercise program three days a week for four weeks under supervision in our cardiopulmonary rehabilitation unit.

BEHAVIORAL

Cardiovascular risk modification

Psychosocial support for physical activity counselling, heart-healthy diet, referral for smoking cessation and stress management.

OTHER

Phone calls with reinforcement feedback

Calls once a week that include symptom inquiries and encouraging feedback on exercise logs.

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Ülkü Nesrin Demirsoy, MD · Gazi University Faculty of Medicine

  • Nihan Burhandağ, MD · Gazi University Faculty of Medicine

  • Levent Karataş, MD · Gazi University Faculty of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-19
Primary Completion
2023-11-16
Completion
2023-12-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06614634 on ClinicalTrials.gov